In parallel with our findings in the pathway enrichment analysis, in a pancreatic cancer related complementary EMT model, it was shown that CHST11, a modifier of glycosaminoglycan sulfation was significantly upregulated in the EMT model (57). The gene discussed is CHST11; the disease is pancreatic neoplasm.